Abstract
Introduction/BackgroundIn treating advanced ovarian cancer marked by extensive peritoneal carcinomatosis, the optimal approach often combines cytoreductive surgery (CRS) and systemic chemotherapy. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is explored as a complement...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
